Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure

Chordoma is a rare malignant axial tumour that develops from embryonic remnants of the notochord. Surgery and irradiation are the standard initial treatment. However, local recurrence is frequent and cytotoxic chemotherapy is inefficient. Transient activity of imatinib, a platelet-derived growth factor receptor inhibitor, was described in a phase II study. Activity of epidermal growth factor re...

متن کامل

Hypotensive response after resistance exercise leading to failure and not to failure in trained men

Hypertension is epidemic disease which post-exercise hypotension (PEH) is useful strategies for hypertension. The aim of present study was to investigate the effects of resistance exercise leading to failure (REF) and resistance exercise not to failure (NREF) on PEH phenomenon in trained men. Eight trained men (age: 22.12±1.81 yr; height: 179±3.44 cm; weight: 73.82±4.29 kg;...

متن کامل

Clivus Chordoma with an arachnoid cyst, coincidence or causative factor?

Clivus chordoma coincidence with arachnoid cyst is rare. We report a rare case of clivus chordoma associated with arachnoid cyst.

متن کامل

Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft

Chordomas are rare primary bone tumors that occur along the neuraxis. Primary treatment is surgery, often followed by radiotherapy. Treatment options for patients with recurrence are limited and, notably, there are no FDA approved therapeutic agents. Development of therapeutic options has been limited by the paucity of preclinical model systems. We have established and previously reported the i...

متن کامل

Surgical Excision of Clivus Chordoma with the Use of Coblator—A Case Report

Chordomas are dysembryogenic tumors originating from the notochordal process [1] [2]. They are aggressive tumours with unique diagnostic and management challenges. Primary therapy is complete surgical removal of the tumour as much as possible. The likelihood of recurrence is high in spite of complete surgical resection. A 52-year-old female patient presented with complaints of decreased vision ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Case Reports in Oncology

سال: 2015

ISSN: 1662-6575

DOI: 10.1159/000371843